Construction and analysis of the abnormal lncRNA–miRNA–mRNA network in hypoxic pulmonary hypertension

CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers

(2020) Subhashree Kumaravel et al.   AMERICAN JOURNAL OF PATHOLOGY

Circ- calm4 Serves as an miR-337-3p Sponge to Regulate Myo10 (Myosin 10) and Promote Pulmonary Artery Smooth Muscle Proliferation

(2020) Junting Zhang et al.   HYPERTENSION

Nucleolar and Spindle Associated Protein 1 (NUSAP1) Promotes Bladder Cancer Progression Through the TGF-β Signaling Pathway

(2020) Shun Gao et al.   OncoTargets and Therapy

miR-210-5p promotes epithelial–mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells

(2020) Wei Liu et al.   Cell Death & Disease

LncRNA CASC2 inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation and migration by regulating the miR-222/ING5 axis

(2020) Yan Han et al.   CELLULAR & MOLECULAR BIOLOGY LETTERS

Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis

(2020) Li Sun et al.   GENE

Absence of the MFG‐E8 gene prevents hypoxia‐induced pulmonary hypertension in mice

(2020) Jun Wang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Novel Therapeutic Targets for Hypoxia-Related Cardiovascular Diseases: The Role of HIF-1

(2020) Minxuan Liu et al.   Frontiers in Physiology

Reversal of Hypoxic Pulmonary Hypertension by Hypoxia-Inducible Overexpression of Angiotensin-(1-7) in Pulmonary Endothelial Cells

(2020) Man-Ling Liu et al.   Molecular Therapy-Methods & Clinical Development

Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension

(2019) Hannes Hudalla et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Long non-coding RNA and mRNA profile analysis of metformin to reverse the pulmonary hypertension vascular remodeling induced by monocrotaline

(2019) Zengxian Sun et al.   BIOMEDICINE & PHARMACOTHERAPY

EDITORIAL: Early evidence for the role of lncRNA TUG1 in vascular remodeling in pulmonary hypertension

(2019) Sébastien Bonnet et al.   CANADIAN JOURNAL OF CARDIOLOGY

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

(2019) Yingyao Zhou et al.   Nature Communications

LncRNA Tug1 involves in the pulmonary vascular remodeling in mice with hypoxic pulmonary hypertension via the microRNA-374c-mediated Foxc1

(2019) Lei Yang et al.   LIFE SCIENCES

Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension

(2019) Yan Xing et al.   MOLECULAR THERAPY

Long noncoding RNAs: emerging roles in pulmonary hypertension

(2019) Qi Jin et al.   HEART FAILURE REVIEWS

Connexin 43 Is a Promising Target for Pulmonary Hypertension due To Hypoxemic Lung Disease

(2019) Claire Bouvard et al.   EUROPEAN RESPIRATORY JOURNAL

Protective Role of Myelocytic Nitric Oxide Synthases against Hypoxic Pulmonary Hypertension in Mice

(2018) Takaaki Ogoshi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling

(2018) Yanwei Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

Danshensu prevents hypoxic pulmonary hypertension in rats by inhibiting the proliferation of pulmonary artery smooth muscle cells via TGF-β-smad3-associated pathway

(2018) Ning Zhang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Circulating microRNAs are associated with Pulmonary Hypertension and Development of Chronic Lung Disease in Congenital Diaphragmatic Hernia

(2018) Marisol Herrera-Rivero et al.   Scientific Reports

LncRNA SNHG14 promotes inflammatory response induced by cerebral ischemia/reperfusion injury through regulating miR-136-5p /ROCK1

(2018) Yu Zhong et al.   CANCER GENE THERAPY

Long noncoding RNA Hoxaas3 contributes to hypoxia-induced pulmonary artery smooth muscle cell proliferation

(2018) Hongyue Zhang et al.   CARDIOVASCULAR RESEARCH

Long non-coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1-AS1

(2018) Katharina Jandl et al.   JOURNAL OF PATHOLOGY

MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.

(2016) Sachindra Raj Joshi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Long noncoding RNA expression profiles of hypoxic pulmonary hypertension rat model

(2016) Xiaohua Wang et al.   GENE

Effect of miR-23a on anoxia-induced phenotypic transformation of smooth muscle cells of rat pulmonary arteries and regulatory mechanism

(2016) Li Yan et al.   Oncology Letters

Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways

(2016) Simon C Rowan et al.   Lancet Respiratory Medicine

Role of Circulating miRNAs as Biomarkers in Idiopathic Pulmonary Arterial Hypertension: Possible Relevance of miR-23a

(2015) Irene Sarrion et al.   Oxidative Medicine and Cellular Longevity

Transgelin as a therapeutic target to prevent hypoxic pulmonary hypertension

(2014) Ruifeng Zhang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Inhibition of LRP5/6-mediated Wnt/β-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats

(2013) Deepthi Alapati et al.   PEDIATRIC RESEARCH

A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?

(2011) Leonardo Salmena et al.   CELL

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

(2009) M. D. Robinson et al.   BIOINFORMATICS